Studies highlight that engineered human CD4 CD26 high T cells, armed with a mesothelin-chimeric antigen receptor, elicit heightened immune responses against successful mesothelioma in NSG mice post-adoptive transfer, surpassing other helper CD4 subsets with the same CAR. This evidence concerns the gene CD4 and mesothelioma.